Suppr超能文献

白细胞介素-18诱导骨桥蛋白介导小鼠心脏纤维化和舒张功能障碍。

IL-18 induction of osteopontin mediates cardiac fibrosis and diastolic dysfunction in mice.

作者信息

Yu Qianli, Vazquez Randy, Khojeini Elham Vali, Patel Chirag, Venkataramani Raj, Larson Douglas F

机构信息

Surgery Department and Sarver Heart Center, College of Medicine, University of Arizona, Tucson, AZ 85724, USA.

出版信息

Am J Physiol Heart Circ Physiol. 2009 Jul;297(1):H76-85. doi: 10.1152/ajpheart.01285.2008. Epub 2009 May 8.

Abstract

Osteopontin (OPN), a key component of the extracellular matrix, is associated with the fibrotic process during tissue remodeling. OPN and the cytokine interleukin (IL)-18 have been shown to be overexpressed in an array of human cardiac pathologies. In the present study, we determined the role of IL-18 in the regulation of cardiac OPN expression and the subsequent interstitial fibrosis and diastolic dysfunction. We demonstrated parallel increases in IL-18, OPN expression, and interstitial fibrosis in murine models of left ventricular pressure and volume overload. Exogenous recombinant (r)IL-18 administered for 2 wk increased cardiac OPN expression, interstitial fibrosis, and diastolic dysfunction. Stimulation of the T helper (Th)1 lymphocyte phenotype with a selective toll-like receptor (TLR)9 agonist induced cardiac IL-18 and OPN expression, which was associated with increased cardiac fibrillar collagen concentrations and interstitial fibrosis resulting in diastolic dysfunction. rIL-18 induced OPN expression and protein levels in primary of cardiac fibroblast cultures. Conditioned media from TLR9-stimulated T lymphocyte cultures induced IL-18 and OPN expression in cardiac fibroblasts, while blockade of the IL-18 receptor with a neutralizing antibody abolished the increase in OPN expression. Furthermore, a mutation in the transcriptional factor interferon regulatory factor (IRF)1 or IRF1 small interfering RNA (siRNA) resulted in the decreased expression of IL-18 and OPN in cardiac fibroblasts. With pressure overload, IRF1-mutant mice showed downregulation of IL-18 and OPN expression in cardiac tissue, reduced cardiac fibrotic development, and increased left ventricular function compared with wild type. These results provide direct evidence that the induction of IL-18 regulates OPN-mediated cardiac fibrosis and diastolic dysfunction.

摘要

骨桥蛋白(OPN)是细胞外基质的关键成分,与组织重塑过程中的纤维化进程相关。OPN和细胞因子白细胞介素(IL)-18在一系列人类心脏疾病中均呈过表达。在本研究中,我们确定了IL-18在调节心脏OPN表达以及随后的间质纤维化和舒张功能障碍中的作用。我们证实在左心室压力和容量超负荷的小鼠模型中,IL-18、OPN表达和间质纤维化呈平行增加。给予外源性重组(r)IL-18 2周可增加心脏OPN表达、间质纤维化和舒张功能障碍。用选择性Toll样受体(TLR)9激动剂刺激辅助性T(Th)1淋巴细胞表型可诱导心脏IL-18和OPN表达,这与心脏纤维状胶原浓度增加和间质纤维化导致舒张功能障碍有关。rIL-18可诱导原代心脏成纤维细胞培养物中OPN的表达和蛋白水平。来自TLR9刺激的T淋巴细胞培养物的条件培养基可诱导心脏成纤维细胞中IL-18和OPN表达,而用中和抗体阻断IL-18受体可消除OPN表达的增加。此外,转录因子干扰素调节因子(IRF)1发生突变或使用IRF1小干扰RNA(siRNA)会导致心脏成纤维细胞中IL-18和OPN表达降低。压力超负荷时,与野生型相比,IRF1突变小鼠心脏组织中IL-18和OPN表达下调,心脏纤维化发展减轻,左心室功能增强。这些结果提供了直接证据,表明IL-18的诱导调节了OPN介导的心脏纤维化和舒张功能障碍。

相似文献

1
IL-18 induction of osteopontin mediates cardiac fibrosis and diastolic dysfunction in mice.
Am J Physiol Heart Circ Physiol. 2009 Jul;297(1):H76-85. doi: 10.1152/ajpheart.01285.2008. Epub 2009 May 8.
2
Visceral Adipose Tissue Drives Cardiac Aging Through Modulation of Fibroblast Senescence by Osteopontin Production.
Circulation. 2018 Aug 21;138(8):809-822. doi: 10.1161/CIRCULATIONAHA.117.031358.
3
Osteopontin Promotes Left Ventricular Diastolic Dysfunction Through a Mitochondrial Pathway.
J Am Coll Cardiol. 2019 Jun 4;73(21):2705-2718. doi: 10.1016/j.jacc.2019.02.074.
4
Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart.
J Am Coll Cardiol. 2004 May 5;43(9):1698-705. doi: 10.1016/j.jacc.2003.11.058.
5
Allopurinol attenuates oxidative stress and cardiac fibrosis in angiotensin II-induced cardiac diastolic dysfunction.
Cardiovasc Ther. 2012 Apr;30(2):117-23. doi: 10.1111/j.1755-5922.2010.00243.x. Epub 2010 Oct 26.
6
T lymphocyte regulation of lysyl oxidase in diet-induced cardiac fibrosis.
Cardiovasc Toxicol. 2010 Sep;10(3):190-8. doi: 10.1007/s12012-010-9078-7.
7
Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy.
Hypertension. 2004 Jun;43(6):1195-201. doi: 10.1161/01.HYP.0000128621.68160.dd. Epub 2004 May 3.
8
Osteopontin-mediated myocardial fibrosis in heart failure: a role for lysyl oxidase?
Cardiovasc Res. 2013 Jul 1;99(1):111-20. doi: 10.1093/cvr/cvt100. Epub 2013 Apr 25.
10
Attenuated development of cardiac fibrosis in left ventricular pressure overload by SM16, an orally active inhibitor of ALK5.
J Mol Cell Cardiol. 2014 Nov;76:148-57. doi: 10.1016/j.yjmcc.2014.08.008. Epub 2014 Aug 26.

引用本文的文献

1
OGT-mediated O-GlcNAcylation regulates macrophage polarization in heart failure via targeting IRF1.
BMC Cardiovasc Disord. 2024 Dec 30;24(1):757. doi: 10.1186/s12872-024-04429-2.
2
AIM2 Deficiency Alleviates Cardiac Inflammation and Hypertrophy in HFD/STZ-Induced Diabetic Mice by Inhibiting the NLRC4/IRF1 Signaling Pathway.
J Cardiovasc Transl Res. 2025 Feb;18(1):94-109. doi: 10.1007/s12265-024-10556-0. Epub 2024 Sep 4.
4
The Multifaceted Role of Osteopontin in Prostate Pathologies.
Biomedicines. 2023 Oct 26;11(11):2895. doi: 10.3390/biomedicines11112895.
5
Mutations in genes related to myocyte contraction and ventricular septum development in non-syndromic tetralogy of Fallot.
Front Cardiovasc Med. 2023 Sep 28;10:1249605. doi: 10.3389/fcvm.2023.1249605. eCollection 2023.
6
Mitochondria and NLRP3 inflammasome in cardiac hypertrophy.
Mol Cell Biochem. 2024 Jul;479(7):1571-1582. doi: 10.1007/s11010-023-04812-1. Epub 2023 Aug 17.
7
Pathophysiological Effects of Various Interleukins on Primary Cell Types in Common Heart Disease.
Int J Mol Sci. 2023 Mar 30;24(7):6497. doi: 10.3390/ijms24076497.
9
Osteopontin - The stirring multifunctional regulatory factor in multisystem aging.
Front Endocrinol (Lausanne). 2022 Dec 22;13:1014853. doi: 10.3389/fendo.2022.1014853. eCollection 2022.
10
Clinical and Molecular Implications of Osteopontin in Heart Failure.
Curr Issues Mol Biol. 2022 Aug 11;44(8):3573-3597. doi: 10.3390/cimb44080245.

本文引用的文献

1
Extracellular matrix turnover and inflammatory markers independently predict functional status and outcome in chronic heart failure.
J Card Fail. 2008 Aug;14(6):467-74. doi: 10.1016/j.cardfail.2008.02.014. Epub 2008 May 27.
2
Aldosterone induces interleukin-18 through endothelin-1, angiotensin II, Rho/Rho-kinase, and PPARs in cardiomyocytes.
Am J Physiol Heart Circ Physiol. 2008 Sep;295(3):H1279-H1287. doi: 10.1152/ajpheart.00148.2008. Epub 2008 Jul 25.
3
Interleukin 18 in the heart.
Shock. 2008 Jul;30(1):3-10. doi: 10.1097/SHK.0b013e318160f215.
4
ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way.
Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):8067-72. doi: 10.1073/pnas.0709684105. Epub 2008 Jun 3.
7
Osteopontin expression is required for myofibroblast differentiation.
Circ Res. 2008 Feb 15;102(3):319-27. doi: 10.1161/CIRCRESAHA.107.160408. Epub 2007 Dec 13.
8
Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction.
Circ Res. 2008 Feb 1;102(2):257-64. doi: 10.1161/CIRCRESAHA.107.158220. Epub 2007 Nov 15.
10
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis.
Nat Med. 2007 Aug;13(8):952-61. doi: 10.1038/nm1613. Epub 2007 Jul 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验